These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 15350655

  • 1. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T.
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [Abstract] [Full Text] [Related]

  • 2. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment.
    Knyihár-Csillik E, Csillik B, Pákáski M, Krisztin-Péva B, Dobó E, Okuno E, Vécsei L.
    Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325
    [Abstract] [Full Text] [Related]

  • 3. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 4. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha.
    Sriram K, Miller DB, O'Callaghan JP.
    J Neurochem; 2006 Feb; 96(3):706-18. PubMed ID: 16405514
    [Abstract] [Full Text] [Related]

  • 5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 6. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
    Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Izal-Azcárate A, Belzunegui S, Marcilla I, López B, Luquin MR.
    J Neuropathol Exp Neurol; 2009 Sep 19; 68(9):977-84. PubMed ID: 19680145
    [Abstract] [Full Text] [Related]

  • 7. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May 19; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 8. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
    Liu J, Wang MW, Gu P, Ma QY, Wang YY, Geng Y, Yuan ZY, Cui DS, Zhang ZX, Ma L, Zhang BH, Zhou MG, Zhu AP.
    Brain Res; 2010 Jul 23; 1345():213-20. PubMed ID: 20546706
    [Abstract] [Full Text] [Related]

  • 9. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.
    Barcia C, Sánchez Bahillo A, Fernández-Villalba E, Bautista V, Poza Y Poza M, Fernández-Barreiro A, Hirsch EC, Herrero MT.
    Glia; 2004 May 23; 46(4):402-9. PubMed ID: 15095370
    [Abstract] [Full Text] [Related]

  • 10. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 23; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 11. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 23; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 12. Microglial activation is inhibited by corticosterone in dopaminergic neurodegeneration.
    Sugama S, Takenouchi T, Kitani H, Fujita M, Hashimoto M.
    J Neuroimmunol; 2009 Mar 31; 208(1-2):104-14. PubMed ID: 19201037
    [Abstract] [Full Text] [Related]

  • 13. Estrogen down-regulates glial activation in male mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication.
    Tripanichkul W, Sripanichkulchai K, Finkelstein DI.
    Brain Res; 2006 Apr 21; 1084(1):28-37. PubMed ID: 16564034
    [Abstract] [Full Text] [Related]

  • 14. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 21; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 15. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 21; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 16. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
    Robertson DC, Schmidt O, Ninkina N, Jones PA, Sharkey J, Buchman VL.
    J Neurochem; 2004 Jun 21; 89(5):1126-36. PubMed ID: 15147505
    [Abstract] [Full Text] [Related]

  • 17. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
    Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T.
    J Pharmacol Exp Ther; 2007 Jul 21; 322(1):274-81. PubMed ID: 17429058
    [Abstract] [Full Text] [Related]

  • 18. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW.
    Brain Res; 2007 May 30; 1150():55-61. PubMed ID: 17397812
    [Abstract] [Full Text] [Related]

  • 19. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M.
    Neurosci Lett; 2006 Jun 19; 401(1-2):183-7. PubMed ID: 16581184
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.